Yuzuru Imai

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 16

Top Topics

Amyotrophic Lateral Sclerosis

Tyrosine Kinase

Endoplasmic Reticulum

Cognitive Impairment

Top Venues

International journal of molecular sciences

Proceedings of the National Academy of Sciences of the United States of America

This page only lists publications with an associated author ORCID identifier.

Publications

Aya Ikeda, Hongrui Meng, Daisuke Taniguchi, Muneyo Mio, Manabu Funayama, Kenya Nishioka, Mari Yoshida, Yuanzhe Li, Hiroyo Yoshino, Tsuyoshi Inoshita, Kahori Shiba-Fukushima, Yohei Okubo, Takashi Sakurai, Taku Amo, Ikuko Aiba, Yufuko Saito, Yuko Saito, Shigeo Murayama, Naoki Atsuta, Ryoichi Nakamura, Genki Tohnai, Yuishin Izumi, Mitsuya Morita, Asako Tamura, Osamu Kano, Masaya Oda, Satoshi Kuwabara, Toru Yamashita, Jun Sone, Ryuji Kaji, Gen Sobue, Yuzuru Imai, Nobutaka Hattori
CHCHD2 P14L, found in amyotrophic lateral sclerosis, exhibits cytoplasmic mislocalization and alters Ca 2+ homeostasis. PNAS nexus 3 (8) (2024)
Aya Ikeda, Hongrui Meng, Daisuke Taniguchi, Muneyo Mio, Manabu Funayama, Kenya Nishioka, Mari Yoshida, Yuanzhe Li, Hiroyo Yoshino, Tsuyoshi Inoshita, Kahori Shiba-Fukushima, Yohei Okubo, Takashi Sakurai, Taku Amo, Ikuko Aiba, Yufuko Saito, Yuko Saito, Shigeo Murayama, Naoki Atsuta, Ryoichi Nakamura, Genki Tohnai, Yuishin Izumi, Mitsuya Morita, Asako Tamura, Osamu Kano, Masaya Oda, Satoshi Kuwabara, Toru Yamashita, Jun Sone, Ryuji Kaji, Gen Sobue, Yuzuru Imai, Nobutaka Hattori
CHCHD2 P14L, found in amyotrophic lateral sclerosis, exhibits cytoplasmic mislocalization and alters Ca 2+ homeostasis. PNAS nexus 3 (8) (2024)
Tatou Iseki, Yuzuru Imai, Nobutaka Hattori
Is Glial Dysfunction the Key Pathogenesis of LRRK2 -Linked Parkinson's Disease? Biomolecules 13 (1) (2023)
Tatou Iseki, Yuzuru Imai, Nobutaka Hattori
Is Glial Dysfunction the Key Pathogenesis of LRRK2 -Linked Parkinson's Disease? Biomolecules 13 (1) (2023)
Tatou Iseki, Yuzuru Imai, Nobutaka Hattori
Is Glial Dysfunction the Key Pathogenesis of LRRK2 -Linked Parkinson's Disease? Biomolecules 13 (1) (2023)
Tatou Iseki, Yuzuru Imai, Nobutaka Hattori
Is Glial Dysfunction the Key Pathogenesis of LRRK2 -Linked Parkinson's Disease? Biomolecules 13 (1) (2023)
Toshiki Tezuka, Daisuke Taniguchi, Mariko Sano, Tomoyo Shimada, Yutaka Oji, Taiji Tsunemi, Aya Ikeda, Yuanzhe Li, Hiroyo Yoshino, Jun Ogata, Kahori Shiba-Fukushima, Manabu Funayama, Kenya Nishioka, Yuzuru Imai, Nobutaka Hattori
Pathophysiological evaluation of the LRRK2 G2385R risk variant for Parkinson's disease. NPJ Parkinson's disease 8 (1) (2022)
Kensuke Daida, Shotaro Shimonaka, Kahori Shiba-Fukushima, Jun Ogata, Hiroyo Yoshino, Ayami Okuzumi, Taku Hatano, Yumiko Motoi, Tomoki Hirunagi, Masahisa Katsuno, Hideo Shindou, Manabu Funayama, Kenya Nishioka, Nobutaka Hattori, Yuzuru Imai
α-Synuclein V15A Variant in Familial Parkinson's Disease Exhibits a Weaker Lipid-Binding Property. Movement disorders : official journal of the Movement Disorder Society 37 (10) (2022)
Jun-Yi Liu, Tsuyoshi Inoshita, Kahori Shiba-Fukushima, Shigeharu Yoshida, Kosuke Ogata, Yasushi Ishihama, Yuzuru Imai, Nobutaka Hattori
Ubiquitination at the lysine 27 residue of the Parkin ubiquitin-like domain is suggestive of a new mechanism of Parkin activation. Human molecular genetics 31 (15) (2022)
Shun Kato, Kohei Arasaki, Natsuki Tokutomi, Yuzuru Imai, Tsuyoshi Inoshita, Nobutaka Hattori, Taeko Sasaki, Miyuki Sato, Yuichi Wakana, Hiroki Inoue, Mitsuo Tagaya
Syntaxin 17, an ancient SNARE paralog, plays different and conserved roles in different organisms. Journal of cell science 134 (22) (2021)
Jun Ogata, Kentaro Hirao, Kenya Nishioka, Arisa Hayashida, Yuanzhe Li, Hiroyo Yoshino, Soichiro Shimizu, Nobutaka Hattori, Yuzuru Imai
A Novel LRRK2 Variant p.G2294R in the WD40 Domain Identified in Familial Parkinson's Disease Affects LRRK2 Protein Levels. International journal of molecular sciences 22 (7) (2021)
Yuzuru Imai
Editorial for the Special Issue "Animal Models of Parkinson's Disease and Related Disorders". International journal of molecular sciences 21 (12) (2020)
Akio Mori, Yuzuru Imai, Nobutaka Hattori
Lipids: Key Players That Modulate α-Synuclein Toxicity and Neurodegeneration in Parkinson's Disease. International journal of molecular sciences 21 (9) (2020)
Yuzuru Imai, Tsuyoshi Inoshita, Hongrui Meng, Kahori Shiba-Fukushima, Kiyotaka Y Hara, Naoya Sawamura, Nobutaka Hattori
Light-driven activation of mitochondrial proton-motive force improves motor behaviors in a Drosophila model of Parkinson's disease. Communications biology 2 (2019)
Yuzuru Imai, Hongrui Meng, Kahori Shiba-Fukushima, Nobutaka Hattori
Twin CHCH Proteins, CHCHD2, and CHCHD10: Key Molecules of Parkinson's Disease, Amyotrophic Lateral Sclerosis, and Frontotemporal Dementia. International journal of molecular sciences 20 (4) (2019)
Akio Mori, Taku Hatano, Tsuyoshi Inoshita, Kahori Shiba-Fukushima, Takahiro Koinuma, Hongrui Meng, Shin-Ichiro Kubo, Spencer Spratt, Changxu Cui, Chikara Yamashita, Yoshimi Miki, Kei Yamamoto, Tetsuya Hirabayashi, Makoto Murakami, Yoshikazu Takahashi, Hideo Shindou, Takashi Nonaka, Masato Hasegawa, Ayami Okuzumi, Yuzuru Imai, Nobutaka Hattori
Parkinson's disease-associated iPLA2-VIA/PLA2G6 regulates neuronal functions and α-synuclein stability through membrane remodeling. Proceedings of the National Academy of Sciences of the United States of America 116 (41) (2019)